Emma Watz

Immunomodulatory properties of mesenchymal stromal cells

Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet

Haemolysis, pure red cell aplasia and red cell antibody formation associated with major and bidirectional ABO incompatible haematopoietic stem cell transplantation.

Assays of different aspects of haemostasis – what do they measure?

NK cells for cancer immunotherapy

The Intravenous Route of Injection Optimizes Engraftment and Survival in the Murine Model of In Utero Hematopoietic Cell Transplantation

Red blood cell-incompatible allogeneic hematopoietic progenitor cell transplantation

Inflammation and tumor progression: signaling pathways and targeted intervention

Tuberculosis and lung damage: from epidemiology to pathophysiology

Adoptive T Cell Immunotherapy for Treatment of Ganciclovir-Resistant Cytomegalovirus Disease in a Renal Transplant Recipient

Host-directed therapies for infectious diseases: current status, recent progress, and future prospects

The Third International Consensus Guidelines on the Management of Cytomegalovirus in Solid-organ Transplantation

How do I approach ABO‐incompatible hematopoietic progenitor cell transplantation? (CME)

Methods for testing platelet function for transfusion medicine

Targeting hypersialylation in multiple myeloma represents a novel approach to enhance NK cell–mediated tumor responses

Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue

Comparative Analysis of Mesenchymal Stem Cells from Bone Marrow, Umbilical Cord Blood, or Adipose Tissue

A review of transfusion practice before, during, and after hematopoietic progenitor cell transplantation

Desensitization for solid organ and hematopoietic stem cell transplantation

Ionizable lipid nanoparticles for in utero mRNA delivery

Critical Parameters for the Isolation of Mesenchymal Stem Cells from Umbilical Cord Blood

Engraftment Capacity of Umbilical Cord Blood Cells Processed by Either Whole Blood Preparation or Filtration

Complete Remission with Reduction of High-Risk Clones following Haploidentical NK-Cell Therapy against MDS and AML

Analysis of Donor and Recipient ABO Incompatibility and Antibody-Associated Complications after Allogeneic Stem Cell Transplantation with Reduced-Intensity Conditioning

Rapid Salvage Treatment With Virus-Specific T Cells for Therapy-Resistant Disease

Transfusion policy in ABO‐incompatible allogeneic stem cell transplantation

Effect of Total Nucleated and CD34+ Cell Dose on Outcome after Allogeneic Hematopoietic Stem Cell Transplantation

Major ABO Blood Group Mismatch Increases the Risk for Graft Failure after Unrelated Donor Hematopoietic Stem Cell Transplantation

A randomized study of buffy coat platelets in platelet additive solution stored 1–5 versus 6–7 days prior to prophylactic transfusion of allogeneic haematopoietic progenitor cell transplant recipients

The Mannheim Cord Blood Project: Experience in Collection and Processing of the First 880 Banked Unrelated Cord Blood Transplants